Characteristics of Helicobacter pylori-seropositive subjects according to the stool antigen test findings: a prospective study
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: In countries with a higher risk of gastric atrophic gastritis, noninvasive tests are helpful for a more reliable diagnosis of Helicobacter pylori infection. The aim of this study was to evaluate the characteristics of seropositive subjects according to their stool H. pylori antigen test, serum pepsinogen (PG) assay, and endoscopic findings. Methods: Consecutive subjects who visited Konkuk University Medical Center for upper gastrointestinal endoscopy for a regular check-up were included in a prospective setting if the serum anti-H. pylori immunoglobulin G assay was positive. A H. pylori antigen stool test was measured using a stool H. pylori antigen enzyme- linked immunosorbent assay kit on the same day as a serum PG assay and endoscopy. Results: Of 318 seropositive subjects, 256 (80.5%) showed positive stool test findings. Subjects with a negative stool test result showed lower serum PG I (p < 0.001) and PG II (p < 0.001) levels and higher PG I/II ratio (p < 0.001) than those with a positive stool test. Chronic atrophic gastritis was more common in the positive stool test group than the negative stool test group on endoscopic finding (p = 0.009). A higher serum PG I level (p = 0.001) and a lower serum PG I/II ratio (p = 0.001) were independent risk factors for the presence of H. pylori antigen in stool. Conclusions: A high serum PG level denotes an ongoing current H. pylori infection with positive stool H. pylori antigen test findings. Seropositive subjects with increased gastric secreting ability tend to have H. pylori in their fecal material as reflected by a positive stool H. pylori antigen test finding.
Abstract
Background/Aims: In countries with a higher risk of gastric atrophic gastritis, noninvasive tests are helpful for a more reliable diagnosis of Helicobacter pylori infection. The aim of this study was to evaluate the characteristics of seropositive subjects according to their stool H. pylori antigen test, serum pepsinogen (PG) assay, and endoscopic findings. Methods: Consecutive subjects who visited Konkuk University Medical Center for upper gastrointestinal endoscopy for a regular check-up were included in a prospective setting if the serum anti-H. pylori immunoglobulin G assay was positive. A H. pylori antigen stool test was measured using a stool H. pylori antigen enzyme- linked immunosorbent assay kit on the same day as a serum PG assay and endoscopy. Results: Of 318 seropositive subjects, 256 (80.5%) showed positive stool test findings. Subjects with a negative stool test result showed lower serum PG I (p < 0.001) and PG II (p < 0.001) levels and higher PG I/II ratio (p < 0.001) than those with a positive stool test. Chronic atrophic gastritis was more common in the positive stool test group than the negative stool test group on endoscopic finding (p = 0.009). A higher serum PG I level (p = 0.001) and a lower serum PG I/II ratio (p = 0.001) were independent risk factors for the presence of H. pylori antigen in stool. Conclusions: A high serum PG level denotes an ongoing current H. pylori infection with positive stool H. pylori antigen test findings. Seropositive subjects with increased gastric secreting ability tend to have H. pylori in their fecal material as reflected by a positive stool H. pylori antigen test finding.
참고문헌 (26)
- Kokkola A, "Diagnosis of Helicobacter pylori infection in patients with atrophic gastritis: comparison of histology, 13C-urea breath test, and serology", Scand J Gastroenterol, 35, pp.138~141 (2000)[DOI]
- Talebkhan Y, "Interobserver variations in histopathological assessment of gastric pathology", Pathology, 41, pp.428~432 (2009)[DOI]
- Korkmaz H, "Comparison of the diagnostic accuracy of five different stool antigen tests for the diagnosis of Helicobacter pylori infection", Helicobacter, 18, pp.384~391 (2013)[DOI]
- Dominguez J, "Comparison of a monoclonal with a polyclonal antibody-based enzyme immunoassay stool test in diagnosing Helicobacter pylori infection before and after eradication therapy", Aliment Pharmacol Ther, 23, pp.1735~1740 (2006)[DOI]
- Shimoyama T, "Comparison of a stool antigen test and serology for the diagnosis of Helicobacter pylori infection in mass survey", Helicobacter, 14, pp.87~90 (2009)[DOI]
- Choi J, "Prospective evaluation of a new stool antigen test for the detection of Helicobacter pylori, in comparison with histology, rapid urease test, (13) C-urea breath test, and serology", J Gastroenterol Hepatol, 26, pp.1053~1059 (2011)[DOI]
- Matsuda M, "Utility and limitations of a method for detecting Helicobacter pylori-specific antigens in the stool", J Gastroenterol, 38, pp.222~228 (2003)[DOI]
- Lin HJ, "Helicobacter pylori stool antigen test in patients with bleeding peptic ulcers", Helicobacter, 9, pp.663~668 (2004)[DOI]
- Manes G, "Accuracy of the stool antigen test in the diagnosis of Helicobacter pylori infection before treatment and in patients on omeprazole therapy", Aliment Pharmacol Ther, 15, pp.73~79 (2001)[DOI]
- Miki K, "Longterm results of gastric cancer screening using the serum pepsinogen test method among an asymptomatic middle-aged Japanese population", Dig Endosc, 21, pp.78~81 (2009)[DOI]
- Nardone G, "Diagnostic accuracy of the serum profile of gastric mucosa in relation to histological and morphometric diagnosis of atrophy", Aliment Pharmacol Ther, 22, pp.1139~1146 (2005)[DOI]
- Lee SP, "Correlation between Helicobacter pylori infection, IgE hypersensitivity, and allergic disease in Korean adults", Helicobacter, 20, pp.49~55 (2015)[DOI]
- Choi HS, "Combining the serum pepsinogen level and Helicobacter pylori antibody test for predicting the histology of gastric neoplasm", J Dig Dis, 15, pp.293~298 (2014)[DOI]
- Gritti I, "Pepsinogens: physiology, pharmacology pathophysiology and exercise", Pharmacol Res, 41, pp.265~281 (2000)[DOI]
- 이선영, "Endoscopic gastritis, serum pepsinogen assay, and Helicobacter pylori infection", The Korean Journal of Internal Medicine, 31(5), pp.835~844 (2016), 대한내과학회[DOI]
- Lee SY, "Validation of western Helicobacter pylori IgG antibody assays in Korean adults", J Med Microbiol, 64, pp.513~518 (2015)[DOI]
- Lee SY, "Current progress toward eradicating Helicobacter pylori in East Asian countries: differences in the 2013 revised guidelines between China, Japan, and South Korea", World J Gastroenterol, 20, pp.1493~1502 (2014)[DOI]
- Tatemichi M, "Clinical significance of IgG antibody titer against Helicobacter pylori", Helicobacter, 14, pp.231~236 (2009)[DOI]
- De Schryver A, "Helicobacter pylori infection: further evidence for the role of feco-oral transmission", Helicobacter, 11, pp.523~528 (2006)[DOI]
- He CY, "Serum pepsinogen II: a neglected but useful biomarker to differentiate between diseased and normal stomachs", J Gastroenterol Hepatol, 26, pp.1039~1046 (2011)[DOI]
- Kumar S, "Pepsinogen-II 100 bp ins", del gene polymorphism and its elevated circulating levels are associated with gastric cancer, particularly with Helicobacter pylori infection and intestinal metaplasia, 2016, pp.19, 808~816
- Lahner E, "Role of noninvasive tests (C-urea breath test and stool antigen test) as additional tools in diagnosis of Helicobacter pylori infection in patients with atrophic body gastritis", Helicobacter, 9, pp.436~442 (2004)[DOI]
- Tu H, "Serum anti-Helicobacter pylori immunoglobulin G titer correlates with grade of histological gastritis, mucosal bacterial density, and levels of serum biomarkers", Scand J Gastroenterol, 49, pp.259~266 (2014)[DOI]
- Hayashi S, "Endoscopic features of lymphoid follicles in Helicobacter pylori-associated chronic gastritis", Dig Endosc, 27, pp.53~60 (2015)[DOI]
- Dore MP, "Novel monoclonal antibody-based Helicobacter pylori stool antigen test", Helicobacter, 9, pp.228~232 (2004)[DOI]
- Yee YK, "Efficacy of enzyme immunoassay for the detection of Helicobacter pylori antigens in frozen stool specimens: local validation", Aliment Pharmacol Ther, 16, pp.1739~1742 (2002)[DOI]